Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma.

ABSTRACT:

SUBMITTER: Suzuki R 

PROVIDER: S-EPMC4318711 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature